Personalized Nanomedicines for Leukemia Patients

Helen E. Heslop

SPORE in Lymphoma

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Hugh-George G Patterton

Reprogramming of the Trypanosoma brucei epigenome during human infection

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Breanne Landry

A New Approach for Acute Myeloid Leukemia Treatment: siRNA Nanoparticles to Turn-Off Infinite Proliferation and Evasion of Apoptosis

Leukaemia

John D Schuetz

Metabolic pathways in leukemia

Leukaemia

Charles G Mullighan

Functional analysis of leukemic CREBBP mutations

Leukaemia

Pediatric oncology or childhood cancer

Tait D Shanafelt

Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Daniel G Tenen

Molecular biology of myeloid differentiation

Leukaemia

Hematology and hematologic malignancies

Marc Nicklaus

In Silico Screening for Cancer Targets

Trachea, bronchus and lung Leukaemia

Hematology and hematologic malignancies Pathology

Everett Meyer

T-cell monitoring and immunotherapy for treating graft-versus-host disease

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma